Ubs Asset Management Americas Inc Veracyte, Inc. Transaction History

Ubs Asset Management Americas Inc

$417 Billion
Q4 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 174,463 shares of VCYT stock, worth $5.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

174,463

Previous 144,404 20.82%

Holding current value

$5.43 Million

Previous $4.91 Million 40.58%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$31.92 - $44.4 $959,483 - $1.33 Million	30,059 Added 20.82%	174,463 $6.91 Million
Q3 2024 Nov 14, 2024	SELL	$21.0 - $35.25 $359,205 - $602,951	-17,105 Reduced 10.59%	144,404 $4.91 Million
Q2 2024 Aug 13, 2024	BUY	$18.86 - $23.55 $1.51 Million - $1.88 Million	80,027 Added 98.21%	161,509 $3.5 Million
Q1 2024 May 15, 2024	SELL	$21.0 - $29.1 $8,190 - $11,349	-390 Reduced 0.48%	81,482 $1.81 Million
Q1 2023 May 15, 2023	BUY	$20.58 - $27.89 $46,160 - $62,557	2,243 Added 2.82%	81,872 $1.83 Million
Q4 2022 Feb 14, 2023	BUY	$15.31 - $29.94 $49,129 - $96,077	3,209 Added 4.2%	79,629 $1.89 Million
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $12,617 - $21,231	761 Added 1.01%	76,420 $1.27 Million
Q2 2022 Aug 12, 2022	SELL	$15.45 - $29.52 $289,826 - $553,765	-18,759 Reduced 19.87%	75,659 $1.51 Million
Q1 2022 May 16, 2022	BUY	$21.94 - $42.51 $344,172 - $666,854	15,687 Added 19.92%	94,418 $2.6 Million
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $25,371 - $37,814	703 Added 0.9%	78,731 $3.24 Million
Q3 2021 Nov 15, 2021	SELL	$35.62 - $52.97 $99,736 - $148,316	-2,800 Reduced 3.46%	78,028 $3.62 Million
Q2 2021 Aug 16, 2021	BUY	$32.94 - $56.62 $353,281 - $607,249	10,725 Added 15.3%	80,828 $3.23 Million
Q1 2021 May 14, 2021	BUY	$44.47 - $81.38 $544,890 - $997,149	12,253 Added 21.18%	70,103 $3.77 Million
Q4 2020 Mar 01, 2021	BUY	$32.49 - $61.88 $343,191 - $653,638	10,563 Added 22.34%	57,850 $2.83 Million
Q3 2020 Nov 13, 2020	BUY	$26.73 - $35.67 $134,478 - $179,455	5,031 Added 11.91%	47,287 $1.54 Million
Q2 2020 Aug 14, 2020	SELL	$19.49 - $28.11 $57,943 - $83,571	-2,973 Reduced 6.57%	42,256 $1.09 Million
Q1 2020 May 15, 2020	BUY	$16.13 - $30.17 $82,843 - $154,953	5,136 Added 12.81%	45,229 $1.1 Million
Q4 2019 Feb 14, 2020	BUY	$20.78 - $29.99 $68,012 - $98,157	3,273 Added 8.89%	40,093 $1.12 Million
Q3 2019 Nov 14, 2019	BUY	$23.87 - $30.93 $214,877 - $278,431	9,002 Added 32.36%	36,820 $883,000
Q2 2019 Aug 15, 2019	BUY	$22.1 - $28.56 $614,777 - $794,482	27,818 New	27,818 $0

Others Institutions Holding VCYT

# of Institutions

338

Shares Held

76.3M

Call Options Held

212K

Put Options Held

18.5K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.23B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Veracyte, Inc. Transaction History